Oncogene Science, Inc.
16Patents
0Active
16Granted
34Portfolio score
Filing activity: Dec 30, 1988 → Jan 6, 1997
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5401638A | Detection and quantification of neu related proteins in the biological fluids of humans | Emerging Cross-Sectional Technologies | 92 | Expired |
| US5580722A | Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease | Chemistry; Metallurgy | 70 | Expired |
| US5665543A | Method of discovering chemicals capable of functioning as gene expression modulators | Emerging Cross-Sectional Technologies | 68 | Expired |
| US5604107A | Detection of neu p185 in cell lysates | Emerging Cross-Sectional Technologies | 53 | Expired |
| US5776502A | Methods of transcriptionally modulating gene expression | Chemistry; Metallurgy | 42 | Expired |
| US5846720A | Methods of determining chemicals that modulate expression of genes associated with cardiovascular disease | Chemistry; Metallurgy | 33 | Expired |
| US5262319A | Method for obtaining bone marrow free of tumor cells using transforming growth factor .beta.3 | Physics | 31 | Expired |
| US5217896A | Monoclonal antibodies recognizing parathyroid hormone-like protein | Human Necessities | 24 | Expired |
| US5443956A | Detection, quantitation and classification of RAS proteins in body fluids and tissues | Emerging Cross-Sectional Technologies | 16 | Expired |
| US5635489A | Methods of prevention of oral mucositis with transforming growth factor .beta. | Human Necessities | 15 | Expired |
| US5824297A | Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof | Human Necessities | 13 | Expired |
| US5863733A | Methods of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators | Chemistry; Metallurgy | 12 | Expired |
| US5976793A | Methods of transcriptionally modulating gene expression and of discovering chemicals capable as gene expression modulators | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5190858A | Monoclonal antibodies directed to epitopes of human transforming growth factor--.alpha. and uses thereof | Physics | 7 | Expired |
| US5817625A | Methods of prevention of oral mucositis with transforming growth factor beta | Human Necessities | 3 | Expired |
| US5262523A | Antibodies reactive with normal and oncogenic forms of the ras p21 protein | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.